In gastric cancer, treatment with Lapatinib plus capecitabine and oxaliplatin also revealed anti-cancer effects on HER2-amplified gastroesophageal adenocarcinoma, especially in Asian and younger patients (Hecht et al., 2016). Here, ERBB2 is linked to cancer.